Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - robert+krug
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Use of HCV NS3/4A Protease Inhibitors as Therapeutics for COVID-19
RPI ID: 2021-001-401 Innovation Summary: A therapeutic composition combines multiple protein inhibitors to target SARS-CoV-2 replication pathways. The method leverages synergistic interactions between inhibitors to enhance antiviral efficacy. It includes formulations for systemic and localized delivery, and supports adaptation to emerging variants....
Published: 3/10/2026
|
Inventor(s):
Khushboo Bafna
,
Robert Krug
,
Aldolfo Garcia-Sastre
,
Kris White
,
Gaetano Montelione
Keywords(s):
COVID19
,
COVID-19 antivirals
,
Hepatitis C viral protease inhibitors
,
Repurposed Drugs
Category(s):
Biotechnology and the Life Sciences